Clinical TrialsSearch results
Number of results: 277
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
- First line therapy for recurrence or metastatic postmenopausal breast cancer
- Nagoya University of School of Medicine Breast and Endocrine Surgery
- 2006-10-01
Other
- Multicenter phase II trial of gemcitabine and S-1 for gallbladder cancer
- gallbladder cancer
- Nagoya University Hospital
- 2008-07-25
Other
- Analysis of Circulating Progenior Cells and Endothelial Function
- arteriosclerosis, coronary heart disease, peripheral artery disease, organ taransplantation, hypertension
- Nagoya University
- 2008-04-01
Other
- Concurrent Treatment of Cardiovascular Disease in Peritoneal Dialysis (PD) patients. Multi-center Randomized Clinical Study with Aldosterone blockade (spironolactone) and Angiotensin Receptor Blocker (ARB) or Angiotensin-Converting-Enzyme Inhibitor (ACEI).
- End-Stage Renal Disease (ESRD) and Cardio-Vascular Disease (CVD)
- Nagoya University
- 2006-10-01
Other
- Study of Circulating Progenitor Cells and Myocardial Infarction
- Ischemic heart disease
- Nagoya University
- 2009-04-01
Other
- A phase II randomized trial in completely resected non-small cell lung cancer comparing paclitaxel / carboplatin with TS-1
- non-small cell lung cancer
- Nagoya City University thoracic oncology study group
- 2008-11-18
Other
- A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)
- Untreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
- Nagoya City University Hospital
- 2008-08-11
Other
- A phase II trial of targeted busulfan and cyclophosphamide conditioning for allogeneic hematopoietic stem cell transplantation for hematological malignancies
- Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
- Nagoya Blood and Marrow Transplantation Group
- 2005-09-13
Other
- A prospective non-randomised phase II study to assess the safety and efficacy of melphalan combined with fludarabine as a reduced conditioning regimen for unrelated bone marrow transplantation for hematological malignancies (C-SHOT 0505)
- Acute myeloid leukemia, Acute lymphocytic leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome, Chronic myelomonocytic leukemia
- Nagoya Blood and Marrow Transplantation Group
- 2006-07-31
Other
- Feasibility study of nonmyeloablative allogeneic stem cell transplantation as a consolidation after autologous peripheral blood stem cell transplantation for multiple myeloma with poor prognosis
- Multiple myeloma
- Nagoya Blood and Marrow Transplantation Group
- 2009-05-13